Does Estrogen Replacement Therapy Predispose to Thrombosis?

References

• Åberg M, Isacson S, Nilsson I M. The fibrinolytic system and postoperative thrombosis following operation of rectal carcinoma. Acta Chir Scand 1974; 140: 352
   Google Scholar
• Abildgaard U, Gravem K, Godal H C. Assay of progressive antithrombin in plasma. Thromb Diath Hae-morrh 1970; 24: 224
   PubMedGoogle Scholar
• Abildgaard U, Lie M, Ødegård D R. Antithrombin (Heparin cofactor) assay with “new” chromogenic substrates (S-2238 and chromozym TH). Thromb Res 1977; 11: 549
   PubMed Web of Science ®Google Scholar
• Ambrus J L., Ambrus C M., Lillie M A., Browne B J., Hanson F W., Niswander K, Witul M, Jung O S., Bartafay-Szabo A. Effect of various estrogen treatment schedules on Antithrombin III levels. Res Commun Chem Pathol Pharmacol 1976; 14: 543
   Google Scholar
• Åstedt B. Low fibrinolytic activity of veins during treatment with ethinyloestradiol. Acta Obstet Gynecol Scand 1971; 50: 279
   PubMed Web of Science ®Google Scholar
• Åstedt B. On the role of estrogens in endometrial carcinogenesis. Acta Obstet Gynecol Scand 1982, suppl. 106: 33
   Google Scholar
• Åstedt B. Oral contraception and some debatable side effects. Acta Obstet Gynecol Scand 1982, suppl. 105: 17
   Google Scholar
• Åstedt B, Bernstein K, Casslen B, Ulmsten U. Estrogens and postoperative thrombosis evaluated by the radioactive iodine method. Surgery 1980; 151: 372
   Google Scholar
• Åstedt B, Isacson S, Nilsson I M., Pandolfi M. Thrombosis and oral contraceptives: Possible predisposition. Br Med J 1973; iv: 631
   Google Scholar
• Åstedt B, Jeppsson S. 17β-estradiol and the fibrinolytic activity of vein walls. J Obstet Gynaecol Br Cwlth 1974; 81: 719
   Google Scholar
• Brandt P, Stenbjerg S. Subcutaneous heparin for thrombosis in pregnant women with hereditary antithrombin deficiency. Lancet 1979; i: 100
   Google Scholar
• Conard J, Samama M, Salomon Y. Antithrombin III and the oestrogen content of combined oestro - progesterone contraceptives. Lancet 1972; ii: 1148
   Google Scholar
• Conard J, Samama M, Horellou M H., Zorn J R., Neau C. Antithrombin III and oral contraception with progesteron-only preparation. Lancet 1979; ii: 471
   Google Scholar
• Dreyer N A., Pizzo S V. Blood coagulation and idiopathic thromboembolism among fertile women. Contraception 1980; 22: 123
   Google Scholar
• Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516
   PubMedGoogle Scholar
• Fagerhol M K., Abildgaard U. Immunological studies on human antithrombin III. Influence of age, sex and use of oral contraceptives on serum concentration. Scand J Haematol 1970; 7: 10
   PubMedGoogle Scholar
• Filip D J., Eckstein J D., Veltkamp J J. Hereditary antithrombin III deficiency and thromboembolic disease. Am J Haematol 1976; 2: 343
   Google Scholar
• Grant E CG. Venous effects of oral contreceptives. Brit Med J 1969; iv: 73
   Google Scholar
• Gyde O HB, Middleton M C., Vaughan G R., Fletcher D J. Antithrombin III deficiency, hypertiglyceridaemia and venous thrombosis. Br Med J 1978; ii: 621
   Google Scholar
• Holmberg L, Ann-Charlotte Kristoffersson, Ingegerd Lecander, Wallén P, Ástedt B. Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase. Scand J Clin Lab Invest 1982; 42: 347
   PubMedGoogle Scholar
• Howie P W., Mallinson A C., Prentice C RM, Horne C HW, McNicol G P. Effect of combined oestrogen—progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. Lancet 1970; ii: 1329
   Google Scholar
• Inman W HW, Vessey M P., Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Brit Med J 1970; ii: 203
   Google Scholar
• Isacson S, Marie Nilsson Inga. Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis. Acta Chir Scand 1972; 138: 313
   PubMedGoogle Scholar
• Johansson L, Hedner U, Marie Nilsson Inga. Familial antithrombin III deficiency as pathogenesis of deep venous thrombosis. Acta Med Scand 1975; 204: 491
   Google Scholar
• von Kaulla E, von Kaulla K N. Antithrombin III and diseases. Am J Clin Pathol 1967; 48: 69
   PubMed Web of Science ®Google Scholar
• von Kaulla E, von Kaulla K N. Oral contraceptives and low antithrombin III activity. Lancet 1970; i: 36
   Google Scholar
• von Kaulla E, von Kaulla K N. Deficiency of antithrombin III activity associated with hereditary thrombosis tendency. J Med 1972; 3: 349
   Google Scholar
• Kobayashi K, Takeda Y. Studies of the effects of oest-radiol, progesterone, Cortisol, thrombophlebitis and typhoid vaccine on synthesis and catabolism of antithrombin III in the dog. Thromb Haem 1977; 37: 111
   Google Scholar
• Laurell C B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45
   PubMed Web of Science ®Google Scholar
• Mackie M, Bennet B, Ogston D, Douglas A S. Familial thrombosis inherited deficiency of antithrombin III. Br Med J 1978; i: 136
   Google Scholar
• McQueen E G. Oestrogen content of oral contraceptives and thromboembolism. New Zeal Med J 1970; 71: 317
   Google Scholar
• Marciniak E, Farley C H., de Simone P A. Familial thrombosis due to antithrombin III deficiency. Blood 1974; 43: 219
   PubMed Web of Science ®Google Scholar
• van der Meer J, Stoepman-van Dalen E A., Jansen J MS. Antithrombin III deficiency in a Dutch family. J Clin Pathol 1973; 26: 532
   Google Scholar
• Ødegård D R., Lie M, Abildgaard U. Heparin cofactor activity measured with an amidolytic method. Thromb Res 1975; 6: 287
   PubMed Web of Science ®Google Scholar
• Sas G, Blasko G, Banhegyi D, Jako J, Palos L A. Abnormal antithrombin III (antithrombin III Budapest) as a cause of a familial thrombophilia. Thromb Diath Haemorrh 1974; 32: 105
   PubMedGoogle Scholar
• Sas G, Pepper D S., Cash J D. Further investigations on antithrombin III in the plasmas of patients with the abnormality of “antithrombin III Budapest”. Thromb Diath Haemorrh 1975; 33: 354
   Google Scholar
• Sørensen P J., Dyerberg J, Stoffersen E, Jensen Krogh M. Familial functional antithrombin III deficiency. Scand J Haematol 1980; 24: 105
   Google Scholar
• Boston Collaborative Drug Surveillance Program. Boston University Medical Center: Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. N Engl J Med 1974; 290: 15
   PubMed Web of Science ®Google Scholar
• 7th International Congress on Fibrinolysis, In Haemostasis. 1984; Vol. 14, Abstracts 63, 64, 66, 183, 184
   Google Scholar